A new study has found that Mounjaro may not only be good at treating diabetes, but could actually help prevent the disease.

In an international trial of 713 adults in nine countries including the U.S. called SUMMIT, participants with heart failure ...

Payers and employers have tightened access to the glucagon-like peptide-1 receptor agonist class once these therapies became ...

SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...

Long-acting pharmacotherapies targeting incretin hormones like glucagon-like peptide-1 (GLP-1) and glucose-dependent ...

More than a quarter of us have learned all we know about weight-loss jabs through social media, so GP Dr Bryony Henderson has helped clear up the myths and misunderstandings ...

Of 200 countries studied by experts by the World Health Organization, in the period between 1990 and 2022 - the most recent ...

In an international trial of 713 adults in nine countries including the U.S. called SUMMIT, participants with heart failure with ...

China: A recent real-world study has revealed promising benefits from combining sodium-glucose co-transporter 2 inhibitors ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

Of 200 countries studied by experts by the World Health Organization, in the period between 1990 and 2022 - the most recent ...

Estrogen is the primary culprit for weight gain in the hips, thighs and buttocks. The ovaries produce less estrogen during ...